Action required: Please refresh your browser
We have recently implemented some changes that require a hard refresh of your browser: Please hold down the CTRL-key and press the F5 key.
After a successful hard refresh, this message should not appear anymore.
More details about this topic are available here »
National Science Foundation Announces Award on Pragmatic Clinical Trials | ||
By: PR Newswire Association LLC. - 13 Dec 2018 | Back to overview list |
|
PALO ALTO, Calif., Dec. 13, 2018 /PRNewswire/ -- The National Science Foundation announces a grant to VMT for developing technology focused on pragmatic clinical trials allowing clinical outcomes to be extracted from real world data. The approach uses artificial intelligence to dive deep into the electronic health record (EHR) for outcome data to enable EHR-based pragmatic clinical trials. Upon completion of the grant, VMT intends to spin out its technology to Verantos, the market leader in regulatory-grade EHR-based studies. As regulatory bodies increasingly look to real world evidence (RWE) to augment the standard of care, pharmaceutical companies are exploring how to run advanced studies to understand real world impact of therapies on important clinical outcomes. Outcomes, such as symptoms, signs, and disease-free survival, are unavailable or inaccurate in claims and EHR structured data. This award will deploy advanced semantic technologies to extract these hidden outcomes and enable valid and relevant RWE. "We are excited to have the support of the National Science Foundation," said Dan Riskin, MD, MBA, principal investigator on the award. "This award reflects advanced science in an area of critical need. The ability to use real world outcomes in pragmatic clinical trials will lead to safer and better targeted care." Support for this grant is provided by the National Science Foundation's Small Business Innovation Research program under award number 1819388. The Small Business Innovation Research (SBIR) / Small Business Technology Transfer (STTR) programs are intended to provide early stage, high-tech small businesses with grants for proof-of-concept / feasibility research that could potentially be followed by grants for cutting-edge, high-quality scientific research and development to de-risk their technologies. "The National Science Foundation supports small businesses with the most innovative, cutting-edge ideas that have the potential to become great commercial successes and make huge societal impacts," said Barry Johnson, Director of the NSF's Division of Industrial Innovation and Partnerships. "We hope that this seed funding will spark solutions to some of the most important challenges of our time across all areas of science and technology." This award reflects the National Science Foundation's intellectual merit and broader impacts review criteria. About the NSF's Small Business Programs About VMT About Verantos Media Contact: View original content to download multimedia:http://www.prnewswire.com/news-releases/national-science-foundation-announces-award-on-pragmatic-clinical-trials-300765160.html SOURCE Verantos; National Science Foundation |
||
|
||
Copyright 2018 PR Newswire Association LLC. | Back to overview list |